Clinical trial
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
NCT01313208
Study timeline
Study start (unknown)2011-03-01Date precision: month
Registry last updated2017-02-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Rheumatoid Arthritisunresolved
Interventions
Sponsors & collaborators
Amgenlead sponsor
Mapped research locations
MontrealQuebec, Canada3Oklahoma CityOklahoma, United States2DallasTexas, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1SeattleWashington, United States1BirminghamAlabama, United States1TampaFlorida, United States1PortlandOregon, United States1JacksonvilleFlorida, United States1DenverColorado, United States1La JollaCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01313208 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.